1 Terushkin V, Stern BJ, Judson MA, Hagiwara M, Pramanik B, Sanchez M, et al. Neurosarcoidosis: presentations and management. Neurologist. 2010;16(1):2–15.
2 Tavee JO, Stern BJ. Neurosarcoidosis. Continuum (Minneap Minn). 2014;20(3):545–59.
3 Hamilton BE, Salzman KL, Osborn AG. Anatomic and pathologic spectrum of pituitary infundibulum lesions. Am J Roentgenol. 2007;188(3):W223–32.
4 Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis – diagnosis and management. QJM. 1999;92(2):103–17.
5 Marangoni S, Argentiero V, Tavolato B. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol. 2006;253(4):488–95.
6 Graf L, Geiser T. La sarcoïdose. Forum Med Suisse. 2018;18(35):695–701.
7 Finger R, Rodriguez R, Schönegg R, Kluckert T, Brutsche M. Sarcoïdose: aperçu clinique. Forum Med Suisse 2013;13(13–14):256–70.
8. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–65.
9 Joshi MN, Whitelaw BC, Carroll PV. Mechanisms in endocrinology: Hypophysitis: diagnosis and treatment. Eur J Endocrinol. 2018;179(3):R151–63.
10 Murialdo G, Tamagno G. Endocrine aspects of neurosarcoidosis. J Endocrinol Invest. 2002;25(7):650–62.
11 Angelousi A, Alexandraki K, Tsoli M, Kaltsas G, Kassi E. Hypophysitis (Including IgG4 and Immunotherapy). Neuroendocrinology. 2020;110(9–10):822–35.
12 Allen RK, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20(2):118–25.
13 Ibitoye RT, Wilkins A, Scolding NJ. Neurosarcoidosis: A clinical approach to diagnosis and management. J Neurol. 2017;264(5):1023–8.
14 Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: A clinical dilemma. Lancet Neurol. 2004;3(7):397–407.
15 Hoitsma E, Drent M, Sharma OP. A pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century. Curr Opin Pulm Med. 2010;16(5):472–9.
16 Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med. 2008;29(3):533–48,ix–x.
17 Baughman RP, Lower EE. Steroid-sparing alternative treatments for sarcoidosis. Clin Chest Med. 1997;18(4):853–64.
18 Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31(6):1189–96.
19 Santos E, Shaunak S, Renowden S, Scolding NJ. Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry. 2010;81(3):241–6.
20 Hostettler KE, Studler U, Tamm M, Brutsche MH. Long-term treatment with infliximab in patients with sarcoidosis. Respiration. 2012;83(3):218–24.